DUBLIN (BUSINESS WIRE) The "BioGeNe Series 2023" conference has been added to ResearchAndMarkets.com's offering.The host is here with a platform for pharmaceutical, biotechnology professionals and technology providers to come together at the BioGeNe 2023 Confex on the 8th - 9th February 2023 in San Diego-USA to di.
/PRNewswire/ Simcere Pharmaceutical Group announces today the appointment of Tamas Oravecz, Ph.D. as Senior Vice President, Chief Scientific Officer of the.
Breakout Ventures, a San Francisco-based seed-stage venture firm that funds what it calls creative biosciences startups, has closed the second fund in its five-year history with $112.5 million in capital commitments. Both of its funds, including a $60 million debut effort that we wrote about in 2017, are backed by Dolby Family Ventures, the Thiel […]